Skip to main navigation
Immuneering Corporation
  • Our Story
    • Overview
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • In the News
  • Our Science
    • Platform
    • Publications
  • Our Pipeline
    • Pipeline
    • Partnerships
  • Patients
    • Overview
    • Disease Focus
    • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
    • Overview
    • Open Positions
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds

Annual Reports

2025 Annual Report
2025 Proxy Statement
2024 Annual Report
2024 Proxy Statement
2023 Annual Report
2023 Proxy Statement
2022 Annual Report
2022 Proxy Statement
2021 Annual Report
 
Immuneering Corporation corporate site

© Immuneering Corporation 2026
All Rights Reserved.

Contact

info@immuneering.com

Boston
245 Main St, 2nd Floor
Cambridge, MA 02142

Media / Investor Inquiries:
ir@immuneering.com

 

 

New York
667 Madison Ave
New York, NY 10065

Partnering Inquiries:
ebrakewood@immuneering.com

 

 

San Diego
10864 Thornmint Road
San Diego, CA 92127

Clinical Trial Inquiries:
clinicaltrials@immuneering.com

Follow Us
  • Linkedin
  • Twitter
Legal
  • Terms of Use
  • Privacy Policy
MENU
  • Our Story
    • Overview
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • In the News
  • Our Science
    • Platform
    • Publications
  • Our Pipeline
    • Pipeline
    • Partnerships
  • Patients
    • Overview
    • Disease Focus
    • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
      • In the News
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
      • Environmental, Social, and Governance (ESG)
    • Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
    • Overview
    • Open Positions